Döring, M., & Johann, P. (2012). Analysis of posaconazole as oral antifungal prophylaxis in pediatric patients under 12 years of age following allogeneic stem cell transplantation. BMC infectious diseases, 12, . https://doi.org/10.1186/1471-2334-12-263
Chicago-Zitierstil (17. Ausg.)Döring, Michaela, und Pascal-David Johann. "Analysis of Posaconazole as Oral Antifungal Prophylaxis in Pediatric Patients Under 12 Years of Age Following Allogeneic Stem Cell Transplantation." BMC Infectious Diseases 12 (2012). https://doi.org/10.1186/1471-2334-12-263.
MLA-Zitierstil (9. Ausg.)Döring, Michaela, und Pascal-David Johann. "Analysis of Posaconazole as Oral Antifungal Prophylaxis in Pediatric Patients Under 12 Years of Age Following Allogeneic Stem Cell Transplantation." BMC Infectious Diseases, vol. 12, 2012, https://doi.org/10.1186/1471-2334-12-263.